A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of Navlimetostat (BMS-986504) Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies
A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of Navlimetostat (BMS-986504) Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies
The purpose of this study is to evaluate the safety and efficacy of Navlimetostat (BMS-986504) monotherapy in participants with advanced or metastatic Non-small Cell Lung Cancer (NSCLC) with homozygous MTAP deletion after progression on prior therapies.
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Anchorage, Alaska 99508, United States
907-257-9851
Beijing, Beijing Municipality 101149, China
Hangzhou, Zhejiang 310016, China
Saint-Herblain, Loire-Atlantique 44800, France
Vandœuvre-lès-Nancy, Meurthe-et-Moselle 54511, France
Frankfurt am Main, Hesse 60590, Germany
Bologna, 40138, Italy
Bucharest, Bucharest 022338, Romania
Florești, Cluj 407280, Romania
40742206212
Hospitalet, Barcelona [Barcelona] 08907, Spain
34932607283
Gothenburg, Västra Götalands Län [se-14] 413 45, Sweden
617-632-6036
909-525-0093
314-747-1171
646-608-3792
330-417-8231
503-215-5696
503-494-3840
206-606-4801
920-202-1555
+61 2 4632 5500
+61 2 85140594
(+61) 731762111
010-8909303
8613860458889
13878873120
8613698091288
86-15553181309
+8615963998868
13588706779
13867622009
33476765467
+33676133810
33383154653
33427857700
33158413091
+33624456290
33156016531
33330143985319
4989440052590
0000
00493455591440
+4922147889050
4993120140155
3929160541
390817770291
390392333683
390264442291
39498215620
+390512142203
390223903829
81471331111
81227288000
81728042503
509120229
+48503022396
40723289606
40727774974
0040744432443
40745646368
40746110096
40744692062
34932746077
34913368263
+34913908546
34917277516
00349422033350000
34955015273
34961245877
45 08-123 79517
+46735-985411
+44 121 3718783
+44 (0) 203 219 5234
+44 (0)191 213 8450